Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: Role of topoisomerase I-Reference-Cited by-同舟云学术

Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: Role of topoisomerase I

Published:1994-06 Issue:11 Volume:47 Page:2105-2110
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Sørensen Boe S.,Jensen Peter B.,Sehested Maxwell,Jensen Palle S.,Kjeldsen Eigil,Nielsen Ole F.,Alsner Jan

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference46 articles.

1. DNA topoisomerase poisons as antitumor drugs;Liu;Annu Rev Biochem,1989

2. DNA topoisomerase I mediated DNA cleavage and cytotoxicity of camptothecin analogs;Hsiang;Cancer Res,1989

3. Characterization of a mammalian mutant with a camptothecin resistant DNA topoisomerase I;Andoh,1987

4. Expression of human DNA topoisomerase I in yeast cells lacking DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin;Bjornsti;Cancer Res.,1989

5. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme DNA complex;Herzberg;Biochemistry,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage;Toxicology in Vitro;2019-03

2. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies;Current Genomics;2017-01-30

3. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents;Mini-Reviews in Medicinal Chemistry;2016-09-02

4. Physicochemical Mechanisms of Synergistic Biological Action of Combinations of Aromatic Heterocyclic Compounds;Organic Chemistry International;2013-02-14

5. Therapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes;Future Medicinal Chemistry;2012-01